Nanoparticles-Assisted Stem Cell Therapy for Ischemic Heart Disease

被引:22
|
作者
Zhu, Kai [1 ,2 ]
Li, Jun [1 ,2 ]
Wang, Yulin [1 ,2 ]
Lai, Hao [1 ,2 ]
Wang, Chunsheng [1 ,2 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200032, Peoples R China
[2] Shanghai Inst Cardiovasc Dis, Shanghai 200032, Peoples R China
基金
美国国家科学基金会;
关键词
IRON-OXIDE NANOPARTICLES; GENE DELIVERY; GROWTH-FACTOR; PLASMID DNA; IN-VIVO; TRACKING; TRANSFECTION; RETENTION; CYTOTOXICITY; EFFICIENCY;
D O I
10.1155/2016/1384658
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell therapy has attracted increasing attention as a promising treatment strategy for cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical and chemical properties, have been widely utilized to assist stem cell therapy. With the help of NPs, stem cells can be genetically engineered for enhanced paracrine profile. To further understand the fate and behaviors of stem cells in ischemic myocardium, imaging NPs can label stem cells and be tracked in vivo under multiple modalities. Besides that, NPs can also be used to enhance stem cell retention in myocardium. These facts have raised efforts on the development of more intelligent and multifunctional NPs for cellular application. Herein, an overview of the applications of NPs-assisted stem cell therapy is given. Key issues and future prospects are also critically addressed.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Stem Cell Therapy for Ischemic Heart Disease
    Jameel, Mohammad Nurulqadr
    Zhang, Jianyi
    ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (12) : 1879 - 1897
  • [2] Stem cell therapy in ischemic heart disease
    Sunkomat, JNE
    Gaballa, MA
    CARDIOVASCULAR DRUG REVIEWS, 2003, 21 (04): : 327 - 342
  • [3] Stem cell therapy for ischemic heart disease
    Hassink, RJ
    Dowell, JD
    de la Rivière, AB
    Doevendans, PA
    Field, LJ
    TRENDS IN MOLECULAR MEDICINE, 2003, 9 (10) : 436 - 441
  • [4] Stem Cell Therapy against Ischemic Heart Disease
    Tsai, I-Ting
    Sun, Cheuk-Kwan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [5] Current State of Stem Cell Therapy for Ischemic Heart Disease
    Thomas J. Povsic
    Current Cardiology Reports, 2016, 18
  • [6] Stem cell therapy for ischemic heart disease: where are we?
    Lapar, Damien J.
    Kron, Irving L.
    Yang, Zequan
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2009, 14 (01) : 79 - 84
  • [7] The current status of stem cell therapy in ischemic heart disease
    Michler, Robert E.
    JOURNAL OF CARDIAC SURGERY, 2018, 33 (09) : 520 - 531
  • [8] Current State of Stem Cell Therapy for Ischemic Heart Disease
    Povsic, Thomas J.
    CURRENT CARDIOLOGY REPORTS, 2016, 18 (02) : 1 - 10
  • [9] Stem Cell-Based Therapy for Ischemic Heart Disease
    Hsiao, Lien-Cheng
    Carr, Carolyn
    Chang, Kuan-Cheng
    Lin, Shinn-Zong
    Clarke, Kieran
    CELL TRANSPLANTATION, 2013, 22 (04) : 663 - 675
  • [10] Mesenchymal Stem Cell Therapy for Ischemic Heart Disease: Advances and Challenges
    Konoplyannikov, Mikhail
    Kotova, Svetlana
    Baklaushev, Vladimir
    Konoplyannikov, Anatoly
    Kalsin, Vladimir
    Timashev, Peter
    Troitskiy, Alexander
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (26) : 3132 - 3142